KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) EPS (Basic) (2016 - 2025)

Boston Scientific's EPS (Basic) history spans 17 years, with the latest figure at $0.46 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 21.05% year-over-year to $0.46; the TTM value through Dec 2025 reached $1.96, up 55.56%, while the annual FY2025 figure was $1.96, 55.56% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.46 at Boston Scientific, down from $0.51 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.53 in Q2 2025 and bottomed at $0.05 in Q4 2021.
  • The 5-year median for EPS (Basic) is $0.26 (2021), against an average of $0.27.
  • The largest annual shift saw EPS (Basic) surged 2200.0% in 2021 before it crashed 69.57% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at $0.05 in 2021, then surged by 80.0% to $0.09 in 2022, then surged by 277.78% to $0.34 in 2023, then rose by 11.76% to $0.38 in 2024, then increased by 21.05% to $0.46 in 2025.
  • Per Business Quant, the three most recent readings for BSX's EPS (Basic) are $0.46 (Q4 2025), $0.51 (Q3 2025), and $0.53 (Q2 2025).